| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Lixte Biotechnology Holdings Inc (NASDAQ: LIXT)
LIXT Technical Analysis
3
| As on 3rd Jul 2025 LIXT STOCK Price closed @ 2.83 and we RECOMMEND Buy for LONG-TERM with Stoploss of 2.29 & Buy for SHORT-TERM with Stoploss of 2.32 we also expect STOCK to react on Following IMPORTANT LEVELS. |
LIXTSTOCK Price
| Open | 3.02 | Change | Price | % |
| High | 4.25 | 1 Day | 0.81 | 40.10 |
| Low | 2.44 | 1 Week | 1.96 | 225.29 |
| Close | 2.83 | 1 Month | 1.52 | 116.03 |
| Volume | 64132966 | 1 Year | 0.77 | 37.38 |
| 52 Week High 3.70 | 52 Week Low 0.71 | ||||
NASDAQ USA Most Active Stocks
| AMRS | 0.14 | 100.00% |
| LCID | 2.16 | 5.37% |
| HCTI | 0.03 | 50.00% |
| NVDA | 159.34 | 1.33% |
| LMDX | 0.02 | 0.00% |
| AKTS | 0.04 | 0.00% |
| PLUG | 1.47 | 5.00% |
| WINT | 0.93 | 20.78% |
| BTBT | 2.94 | 11.79% |
| LILM | 0.05 | 0.00% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| LIXT Daily Charts |
LIXT Intraday Charts |
Whats New @ Bazaartrend |
LIXT Free Analysis |
|
|
LIXT Important Levels Intraday
| RESISTANCE | 6.32 |
| RESISTANCE | 5.20 |
| RESISTANCE | 4.51 |
| RESISTANCE | 3.82 |
| SUPPORT | 1.84 |
| SUPPORT | 1.15 |
| SUPPORT | 0.46 |
| SUPPORT | -0.66 |
LIXT Forecast July 2025
| 4th UP Forecast | 5.05 |
| 3rd UP Forecast | 4.34 |
| 2nd UP Forecast | 3.9 |
| 1st UP Forecast | 3.46 |
| 1st DOWN Forecast | 2.2 |
| 2nd DOWN Forecast | 1.76 |
| 3rd DOWN Forecast | 1.32 |
| 4th DOWN Forecast | 0.61 |
LIXT Weekly Forecast
| 4th UP Forecast | 4.10 |
| 3rd UP Forecast | 3.69 |
| 2nd UP Forecast | 3.44 |
| 1st UP Forecast | 3.19 |
| 1st DOWN Forecast | 2.47 |
| 2nd DOWN Forecast | 2.22 |
| 3rd DOWN Forecast | 1.97 |
| 4th DOWN Forecast | 1.56 |
LIXT Forecast2025
| 4th UP Forecast | 10.08 |
| 3rd UP Forecast | 7.75 |
| 2nd UP Forecast | 6.32 |
| 1st UP Forecast | 4.88 |
| 1st DOWN Forecast | 0.78 |
| 2nd DOWN Forecast | -0.66 |
| 3rd DOWN Forecast | -2.09 |
| 4th DOWN Forecast | -4.42 |
Lixte Biotechnology Holdings Inc ( NASDAQ USA Symbol : LIXT )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
LIXT Business Profile
Lixte Biotechnology Holdings, Inc. operates as a drug discovery company that uses biomarker technology to identify enzyme targets related with serious common diseases and designs novel compounds to attack those targets. The company primarily focuses on inhibitors of protein phosphatases that are used alone and in combination with cytotoxic agents and/or x-ray and immune checkpoint blockers; and encompasses two major categories of compounds at various stages of pre-clinical and clinical development. It develops two series of pharmacologically active drugs, which include the LB-100 series that consists of novel structures, which might be useful in the treatment of cancers, and vascular and metabolic diseases; and LB-200 series for the treatment of chronic hereditary diseases, such as Gaucher's disease, as well as cancer and neurodegenerative diseases. Lixte Biotechnology Holdings, Inc. has a clinical trial research agreement with the Moffitt Cancer Center and Research Institute Hospital Inc.; collaboration agreement for an investigator-initiated clinical trial with the Spanish Sarcoma Group, as well as Netherlands Cancer Institute and Oncode Institute. The company was founded in 2005 and is based in East Setauket, New York. Address: 248 Route 25A, No. 2, East Setauket, NY, United States, 11733
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service